title: Modified β-cyclodextrin inclusion complex to improve the physicochemical properties of albendazole. complete in vitro evaluation and characterization.
abstract: The potential use of natural cyclodextrins and their synthetic derivatives have been studied extensively in pharmaceutical research and development to modify certain properties of hydrophobic drugs. The ability of these host molecules of including guest molecules within their cavities improves notably the physicochemical properties of poorly soluble drugs, such as albendazole, the first chosen drug to treat gastrointestinal helminthic infections. Thus, the aim of this work was to synthesize a beta cyclodextrin citrate derivative, to analyze its ability to form complexes with albendazole and to evaluate its solubility and dissolution rate. The synthesis progress of the cyclodextrin derivative was followed by electrospray mass spectrometry and the acid-base titration of the product. The derivative exhibited an important drug affinity. Nuclear magnetic resonance experiments demonstrated that the tail and the aromatic ring of the drug were inside the cavity of the cyclodextrin derivative. The inclusion complex was prepared by spray drying and full characterized. The drug dissolution rate displayed exceptional results, achieving 100% drug release after 20 minutes. The studies indicated that the inclusion complex with the cyclodextrin derivative improved remarkably the physicochemical properties of albendazole, being a suitable excipient to design oral dosage forms.
authors.affiliation: IQUIR-CONICET, Facultad de Ciencias Bioquímicas y Farmacéuticas, UNR, Rosario, Santa Fe, Argentina ; Área Técnica Farmacéutica, Facultad de Ciencias Bioquímicas y Farmacéuticas, UNR, Rosario, Santa Fe, Argentina.
authors.forename: Agustina
authors.initials: A
authors.lastname: García
authors.affiliation: IQUIR-CONICET, Facultad de Ciencias Bioquímicas y Farmacéuticas, UNR, Rosario, Santa Fe, Argentina ; Área Técnica Farmacéutica, Facultad de Ciencias Bioquímicas y Farmacéuticas, UNR, Rosario, Santa Fe, Argentina.
authors.forename: Darío
authors.initials: D
authors.lastname: Leonardi
authors.affiliation: Área Farmacognosia, Facultad de Ciencias Bioquímicas y Farmacéuticas, UNR, Rosario, Santa Fe, Argentina.
authors.forename: Mario Oscar
authors.initials: MO
authors.lastname: Salazar
authors.affiliation: IQUIR-CONICET, Facultad de Ciencias Bioquímicas y Farmacéuticas, UNR, Rosario, Santa Fe, Argentina ; Área Técnica Farmacéutica, Facultad de Ciencias Bioquímicas y Farmacéuticas, UNR, Rosario, Santa Fe, Argentina.
authors.forename: María Celina
authors.initials: MC
authors.lastname: Lamas
mesh_terms: D015766:Albendazole / Q000737:chemistry*; D002152:Calorimetry, Differential Scanning; D055598:Chemical Phenomena; D002951:Citrates / Q000737:chemistry*; D009682:Magnetic Resonance Spectroscopy; D044367:Phase Transition; D012995:Solubility; D021241:Spectrometry, Mass, Electrospray Ionization; D017550:Spectroscopy, Fourier Transform Infrared; D014961:X-Ray Diffraction; D047392:beta-Cyclodextrins / Q000737:chemistry*
chemical_list: D002951:Citrates; D047392:beta-Cyclodextrins; D015766:Albendazole; C031215:betadex